ReviewJACC. Asia2022

Clinical Benefits of Sodium-Glucose Cotransporter 2 Inhibitors and the Mechanisms Underlying Their Cardiovascular Effects.

Yoshiaki Kubota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.